| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 09/07/2005 | CN1665820A Therapeutic or preventive agent for nausea/vomiting |
| 09/07/2005 | CN1665818A N-aryl diazaspiracyclic compounds and methods of preparation and use thereof |
| 09/07/2005 | CN1665815A Novel tetracyclo-aryl-carbonyl indoles used as therapeutical agents with 5-hydroxy-tryptamine receptor affinity, their preparation process and pharmaceutical compounds containing same |
| 09/07/2005 | CN1665805A Method for preparing optical purity or optically concentrated sulfoxide compounds comprising amorphous esomeprazole and its salts |
| 09/07/2005 | CN1665804A 4, 4-disubstituted piperidine derivatives having CCR3 antagonism |
| 09/07/2005 | CN1665803A Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical, compositions containing the novel forms and methods for treating nausea using them |
| 09/07/2005 | CN1665801A Anti tubercular drug: compositions and methods |
| 09/07/2005 | CN1665800A Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions |
| 09/07/2005 | CN1665799A Motilide compounds |
| 09/07/2005 | CN1665798A Refreshment capable of stimulating movement of digestive tract |
| 09/07/2005 | CN1665791A Quinazoline derivatives |
| 09/07/2005 | CN1665780A Tricyclic steroid hormone nuclear receptor modulators |
| 09/07/2005 | CN1665763A Crystallization of polyol compositions, crystalline polyol composition product and use thereof |
| 09/07/2005 | CN1665541A Liquid formulations with a high concentration of human growth hormone (hgh) comprising glycine |
| 09/07/2005 | CN1665540A Liquid formulations with a high concentration of human growth hormone (hgh) comprising glycine |
| 09/07/2005 | CN1665537A Use of CETP inhibitors and optionally HMG COA reductable inhibitors and/or antihypertensive agents |
| 09/07/2005 | CN1665524A Use of alanyl-aminopeptidase inhibitors and pharmaceutical compositions containing said inhibitors |
| 09/07/2005 | CN1665513A 1, 3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 09/07/2005 | CN1665508A Use of pyrazolo[4, 3-d]pyrimidines |
| 09/07/2005 | CN1665501A Novel compounds as opioid receptor modulators |
| 09/07/2005 | CN1665493A Hypoglycemic agent, liver protecting agent and anticancer agent containing lignans originating in hongdoushan |
| 09/07/2005 | CN1663610A Lysozyme preparation |
| 09/07/2005 | CN1663608A Medicine for treating infantile anorexia |
| 09/07/2005 | CN1663597A Qi-invigorating, blood-nourishing medicinal composition and its preparing method |
| 09/07/2005 | CN1663590A Buccal tablet of chrysanthemum flower |
| 09/07/2005 | CN1663586A Novel formulation for treating liver and gallbladder calculi and its preparation process |
| 09/07/2005 | CN1663573A A stable and safe microecological formulation, its preparation and usage |
| 09/07/2005 | CN1663567A Compound menonine and Vitamin B1 freeze-dried injection and its preparation |
| 09/07/2005 | CN1663450A Health-caring food with rapid and sustain gastric mucosa protection function |
| 09/07/2005 | CN1663449A Heath-caring product having protecting function for chemical liver injury |
| 09/07/2005 | CN1217943C New use and novel N-azabicyclo-amide derivatives |
| 09/07/2005 | CN1217939C Compound of phycocyania of blue-green algae, its preparing method and usage |
| 09/07/2005 | CN1217938C Bis-arylsulfones |
| 09/07/2005 | CN1217927C Novel 1, 2-diphenzylazetidinones, method for producing the same, medicaments containing said compounds, and the use thereof for treating disorders of the lipid metabolism |
| 09/07/2005 | CN1217697C Peptide antagonists of zonulin and methods for use of same |
| 09/07/2005 | CN1217696C Health caring and face nursing composition of natural materials |
| 09/07/2005 | CN1217695C Appetizing digestion-promoting oral liquid and the preparation thereof |
| 09/07/2005 | CN1217690C Chinese medicine for treating bacillary dysentery and producing method thereof |
| 09/07/2005 | CN1217688C Medicine for treating chronic gastritis and preparing process thereof |
| 09/07/2005 | CN1217684C Chinese medicine for repairing gastric mucosa |
| 09/07/2005 | CN1217679C Traditional Chinese medicinal powder pasted on shenchueh acupoint for treating astriction |
| 09/07/2005 | CN1217672C Medicine for preventing and treating hepatitis prepared from mudlump and its preparation |
| 09/07/2005 | CN1217665C Measalazine controlled redease oral pharmaceutical compositions |
| 09/07/2005 | CN1217660C IL-8 receptor antagonists |
| 09/06/2005 | US6939990 Derivatives of dicarboxylic acid having pharmaceutical properties |
| 09/06/2005 | US6939989 Side-chain halogenated amino dicarboxylic acid derivatives as medicaments for treating cardiovascular diseases |
| 09/06/2005 | US6939971 (R)-2-(((3-methyl-4-(2,2,2-trifluoroethoxy)-2 -pyridinyl)methyl)sulfinyl)-1H-benzimidazole, (R(+)-lansoprazole); antiulcer agent |
| 09/06/2005 | US6939900 Dental resin cements having improved handling properties |
| 09/06/2005 | US6939891 Heterocyclic ureas, their preparation and their use as vanilloid receptor antagonists |
| 09/06/2005 | US6939883 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 09/06/2005 | US6939881 Methods for prevention of ulcers and improving physiological performance |
| 09/06/2005 | US6939867 Phenyl sulfamide derivatives as dietetics, antidiabetics, and hypotensive agents |
| 09/06/2005 | US6939860 Composition and method for treatment of neoplastic diseases associated with elevated matrix metalloproteinase activities using catechin compounds |
| 09/06/2005 | US6939568 Hydrated dressing containing metal microbiocide |
| 09/06/2005 | US6939563 Use of a polyol selected from polyoxyethylene glycol or ethylene glycol-propylene glycol copolymer, a non-fermented osmotic laxative as an anticarcinogenic agent for treating colon or rectum cancer |
| 09/06/2005 | CA2217479C Derivatives of phenoxyethylamine having a high affinity for 5-ht1a receptor, their preparation procedure, their application as medications and pharmaceutical compounds containing them |
| 09/06/2005 | CA2127536C Phenyl-imidazolidinone derivatives, process for their preparation and their use as 5ht3 receptor antagonists |
| 09/05/2005 | CA2460602A1 Pancreatic multipotent progenitor cells |
| 09/01/2005 | WO2005080397A2 Fused hetrocyclic compounds and their use as metabotropic receptor antagonists for the treatment of gastrointestinal disorders |
| 09/01/2005 | WO2005080385A1 Indanol derivative |
| 09/01/2005 | WO2005080377A1 COMPOUND HAVING TGF-β INHIBITORY ACTIVITY AND PHARMACEUTICAL COMPOSITION CONTAINING SAME |
| 09/01/2005 | WO2005080374A1 New compounds useful for the synthesis of s- and r-omeprazole and a process for their preparation |
| 09/01/2005 | WO2005079824A1 Beverage or drug containing bamboo extract as main ingredient |
| 09/01/2005 | WO2005079788A1 Amino alcohol compound |
| 09/01/2005 | WO2005079778A2 Medicaments for treating barrett’s oesophagus |
| 09/01/2005 | WO2005018627A8 Alpha-aminoamide derivatives useful as anti-inflammatory agents |
| 09/01/2005 | WO2002083873A3 Enzymes |
| 09/01/2005 | US20050192350 Aspirin-triggered lipoxins as modulators of diseases associated with polymorphoneutrophil inflammation; antiinflammatory agents |
| 09/01/2005 | US20050192336 Treatment may include administration of a second active agent, including but not limited to, an anti-inflammatory agent, an immnunosuppressant, mycophenolate mofetil, a biologic agent, or a Cox-2 inhibitor |
| 09/01/2005 | US20050192335 Acyloxypyrrolidine derivatives, preparation thereof and application thereof in therapeutic |
| 09/01/2005 | US20050192334 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands |
| 09/01/2005 | US20050192332 Pyrazolecarboxylic acid tricyclic derivatives, preparation and pharmaceutical compositions containing same |
| 09/01/2005 | US20050192313 Thio substituted with a hetero multiring group; sleepiness, promotion of wakefulness, Parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, stimulation of appetite and weight gain, attention deficit hyperactivity disorder |
| 09/01/2005 | US20050192306 Pyrimidine derivatives as selective inhibitors of COX-2 |
| 09/01/2005 | US20050192238 Modulation of the expression of genes dependent on stat-1 |
| 09/01/2005 | US20050192235 Compositions and methods for treating or preventing diseases of body passageways |
| 09/01/2005 | US20050191690 Membrane proteins for identifying modulators for prevention and treatment of infection, cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory and metabolic disorders |
| 09/01/2005 | US20050191641 Nucleotide sequences coding hydrolase for use as tool in identifying modulators for prevention and treatment of digestion, coagulation, diabetic, cell proliferative, urogenital, eating and nervous system gynecological disorders |
| 09/01/2005 | US20050191302 Administering an inducer (sulfasalazine) of hepatic stellate cell apoptosis; selective delivery; fibrosis; inhibiting interaction of a tissue inhibitor of a matrix metalloprotease (TIMP) with a matrix metalloprotease |
| 09/01/2005 | US20050191301 Mammalian EPO mimetic CH1 deleted mimetibodies, compositions, methods and uses |
| 09/01/2005 | US20050191300 Immunotherapy of autoimmune disorders using antibodies which target B-cells |
| 09/01/2005 | US20050191275 Method for short-term and long-term drug dosimetry |
| 09/01/2005 | DE102004007854A1 Stabile, wässrige Formulierung für Benzimidazole Stable, aqueous formulation for benzimidazoles |
| 09/01/2005 | DE102004003030A1 Composition containing a dihydroanthracene-disulfonic acid derivative, useful for treating inflammation of internal organs, e.g. ulcers, and cancer |
| 09/01/2005 | CA2557539A1 Indanol derivative |
| 09/01/2005 | CA2556320A1 Fused heterocyclic compounds and their use as metabotropic glutamate receptor antagonists for the treatment of gastrointestinal disorders |
| 09/01/2005 | CA2554894A1 Triazole compounds and their use as metabotropic glutamate receptor antagonists |
| 09/01/2005 | CA2498966A1 Novel pyrazole analogs acting on cannabinoid receptors |
| 09/01/2005 | CA2498644A1 Anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (no) production |
| 08/31/2005 | EP1568699A1 1,3-dihydroimidazole fused-ring compound |
| 08/31/2005 | EP1568685A1 Aminoadamantane derivatives as therapeutic agents |
| 08/31/2005 | EP1568377A1 Cysteine protease inhibitor |
| 08/31/2005 | EP1567644A2 Tissue specific genes and gene clusters |
| 08/31/2005 | EP1567184A1 Phosphoprotein preparations for bioactive metal ion delivery and teeth remineralisation |
| 08/31/2005 | EP1567182A2 Preventing desensitization of receptors |
| 08/31/2005 | EP1567181A2 Methods for treatment of helicobacter pylori-associated disorders |
| 08/31/2005 | EP1567167A2 Methods for treating gastroesophageal reflux disease |
| 08/31/2005 | EP1567163A2 Method of treating nausea, vomiting, retching or any combination thereof |
| 08/31/2005 | EP1567154A2 Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases |
| 08/31/2005 | EP1567150A1 Derivatives of indole-3-carboxamide, preparation method thereof and application of same in therapeutics |